← brief for 2026-09-10 · Slowing decline

Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.

Key takeaways

Scientists built a new lab compound called QX-31 that shuts off NLRP3, a protein switch that drives inflammation and kidney scarring. It works by locking onto a specific spot on the protein, which older drugs miss and which damaged kidneys can escape less easily. In lab-grown mini kidney tissue and in mice, the compound reversed some scarring. This was in cells and animals, not in people, so there is no way yet to know if it helps humans.

Who did this work

Wu WH · Yao Y · Liu K · Ma ZY · Wei LY · Li YX · Niu KM · Cai J · Qi XY · Chen HK · Xiao W · Zhang XW

Source

Article · PubMed, fibrosis reversal · 2026 Sep 10
https://pubmed.ncbi.nlm.nih.gov/42720495/